Restarting Thalidomide-Dexamethasone Regimen in a Post-Abortive Female with Multiple Myeloma: Effective Clinical Response Possible

Nowadays, the prevalence of Multiple Myeloma (MM) seems to have been increasing among young females. Here, we report that thalidomide is contraindicated in pregnant women diagnosed with MM and those desirous of subsequent pregnancy. In this case report, we compared the clinical response of Thalidomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rehman, Suhailur, Arif, S. H., Kumar, Amit, Khan, A. Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767291/
https://www.ncbi.nlm.nih.gov/pubmed/29340127
_version_ 1783292510284546048
author Rehman, Suhailur
Arif, S. H.
Kumar, Amit
Khan, A. Q.
author_facet Rehman, Suhailur
Arif, S. H.
Kumar, Amit
Khan, A. Q.
author_sort Rehman, Suhailur
collection PubMed
description Nowadays, the prevalence of Multiple Myeloma (MM) seems to have been increasing among young females. Here, we report that thalidomide is contraindicated in pregnant women diagnosed with MM and those desirous of subsequent pregnancy. In this case report, we compared the clinical response of Thalidomide-Dexamethasone therapy in a post-abortive woman with persistently elevated β-hCG levels due to retained products of conception, undergoing hysterectomy later. This case report underlines the clinical significance of age, the effect of Thalidomide-Dexamethasone therapy even after initial discontinuation and the response to high β-hCG levels.
format Online
Article
Text
id pubmed-5767291
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
record_format MEDLINE/PubMed
spelling pubmed-57672912018-01-16 Restarting Thalidomide-Dexamethasone Regimen in a Post-Abortive Female with Multiple Myeloma: Effective Clinical Response Possible Rehman, Suhailur Arif, S. H. Kumar, Amit Khan, A. Q. Int J Hematol Oncol Stem Cell Res Case Report Nowadays, the prevalence of Multiple Myeloma (MM) seems to have been increasing among young females. Here, we report that thalidomide is contraindicated in pregnant women diagnosed with MM and those desirous of subsequent pregnancy. In this case report, we compared the clinical response of Thalidomide-Dexamethasone therapy in a post-abortive woman with persistently elevated β-hCG levels due to retained products of conception, undergoing hysterectomy later. This case report underlines the clinical significance of age, the effect of Thalidomide-Dexamethasone therapy even after initial discontinuation and the response to high β-hCG levels. Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2017-10-01 /pmc/articles/PMC5767291/ /pubmed/29340127 Text en Copyright : © International Journal of Hematology-Oncology and Stem Cell Research & Tehran University of Medical Sciences This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Rehman, Suhailur
Arif, S. H.
Kumar, Amit
Khan, A. Q.
Restarting Thalidomide-Dexamethasone Regimen in a Post-Abortive Female with Multiple Myeloma: Effective Clinical Response Possible
title Restarting Thalidomide-Dexamethasone Regimen in a Post-Abortive Female with Multiple Myeloma: Effective Clinical Response Possible
title_full Restarting Thalidomide-Dexamethasone Regimen in a Post-Abortive Female with Multiple Myeloma: Effective Clinical Response Possible
title_fullStr Restarting Thalidomide-Dexamethasone Regimen in a Post-Abortive Female with Multiple Myeloma: Effective Clinical Response Possible
title_full_unstemmed Restarting Thalidomide-Dexamethasone Regimen in a Post-Abortive Female with Multiple Myeloma: Effective Clinical Response Possible
title_short Restarting Thalidomide-Dexamethasone Regimen in a Post-Abortive Female with Multiple Myeloma: Effective Clinical Response Possible
title_sort restarting thalidomide-dexamethasone regimen in a post-abortive female with multiple myeloma: effective clinical response possible
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767291/
https://www.ncbi.nlm.nih.gov/pubmed/29340127
work_keys_str_mv AT rehmansuhailur restartingthalidomidedexamethasoneregimeninapostabortivefemalewithmultiplemyelomaeffectiveclinicalresponsepossible
AT arifsh restartingthalidomidedexamethasoneregimeninapostabortivefemalewithmultiplemyelomaeffectiveclinicalresponsepossible
AT kumaramit restartingthalidomidedexamethasoneregimeninapostabortivefemalewithmultiplemyelomaeffectiveclinicalresponsepossible
AT khanaq restartingthalidomidedexamethasoneregimeninapostabortivefemalewithmultiplemyelomaeffectiveclinicalresponsepossible

Ejemplares similares